NPS Pharmaceuticals Inc. Said Thursday it has completed a $4 million second-roundfinancing with venture capital firms S.R. One Ltd. and Chancellor Capital Management Inc.,an institutional investment management firm.

NPS of Salt Lake City said the funding will enable it to accelerate its development ofcalcium-related therapeutics for hyperparathyroidism, osteoporosis, and stroke.

No Comments